Vericel Corporation (VCEL) Fundamentals

Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company dedicated to the identification, development, and commercialization of innovative therapies that enable the body to repair and regenerate damaged tissues and organs to restore normal structure and function. Vericel has marketed products and the goal is to become the leader in cell therapy and regenerative medicine by developing, manufacturing and marketing best-in-class therapies for patients with significant unmet medical needs. The Company operates in one reportable segment: the research, product development, manufacture and distribution of patient-specific, expanded cellular therapies for use in the treatment of specific diseases.
SHARE INFORMATION
Market Cap$ 1,290,614,116
Shares Outstanding47,119,902
Float33,940,042
Percent Float72.03%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 156,184,000
Latest Fiscal EPS$ -0.16
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions505
Institutional Holdings Date2022-04-30
Institutional Bought Previous 3 Months6,544,529
Institutional Holdings Percent0.0%
Institutional Sold Previous 3 Months8,460,072
Insider Holdings Date2022-03-31
Insider Bought Previous 3 Months694,095
Insider Holdings Percent4.0
Insider Sold Previous 3 Months95,850
Insider Shares Owned1,875,506
TRADING INFO
52 Week High$ 68.94
52 Week Low$ 25.11
52 Week High Change$ -47.84
21 Day Moving Average$ 29.2195
21 Day Extended Moving Average$ 29.4368
50 Day Moving Average$ 33.4388
50 Day Extended Moving Average$ 32.3335
200 Day Moving Average$ 40.8877
200 Day Extended Moving Average$ 38.4668
10 Day Average Volume553,070
20 Day Average Volume584,856
30 Day Average Volume550,797
50 Day Average Volume531,535
Alpha0.038392
Beta1.9599
Standard Deviation0.197504
R20.220666
7 Day Price Change$ -0.91
7 Day Percent Change-3.22%
21 Day Price Change$ -1.11
21 Day Percent Change-3.89%
30 Day Price Change$ -11.57
30 Day Percent Change-29.7%
Month to Date Price Change$ -1.11
Month to Date Percent Change-3.89%
Quarter to Date Price Change$ -10.83
Quarter to Date Percent Change-28.34%
180 Day Price Change$ -16.94
180 Day Percent Change-38.21%
200 Day Price Change$ -18.45
200 Day Percent Change-40.25%
Year to Date Price Change$ -11.91
Year to Date Percent Change-30.31%

Vericel Corporation (VCEL) Key Ratios

PROFITABILITY
EBIT Margin-7.3%
EBITDA Margin-5.4%
Pre-Tax Profit Margin-6.6%
Profit Margin Count-7.22%
Gross Margin67.0%
Profit Margin TOT-7.22%
INCOME STATEMENTS
Revenue$ 157,690,000
Revenue Per Share$ 3.3466
Revenue (3 Years)$ 15.26
Revenue (5 Years)$ 23.86
FINANCIAL STRENGTH
Price to Tangible Book7.50
Total Debt To Equity0.30
Int Coverage-547.90
Current Ratio7.00
Leverage Ratio1.40
Quick Ratio6.10
Long Term Debt To Capital0.21
VALUATION MEASURES
PE Ratio-114.10
Enterprise Value$ 1,239,327,115
Price to Sales8.1845
Price to Free Cash93.70
PE High Last 5 Years984.90
Price To Book7.50
Price To Cash Flow57.10
PE Low Last 5 Years-63.80
Price to Tangible Book7.50
MANAGEMENT EFFECTIVENESS
Receivables Turnover4.90
Invoice Turnover4.20
Assets Turnover0.70
Return Assets-5.12
Return on Equity-7.39
Return on Capital-5.54

Vericel Corporation (VCEL) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorPricewaterhouseCoopers LLP
CEODominick C. Colangelo
Emplyoees281
Last AuditUQ
CIK0000887359
IndustryBiotechnology
SectorHealthcare
NAICSBiological Product (except Diagnostic) Manufacturing(325414)
CONTACT INFO
Address64 Sidney Street
Cambridge, MA 2139
Websitehttps://www.vcel.com
Facsimile+1 617 588-5554
Telephone+1 800 556-0311
Emailir@vcel.com


Your Recent History
NASDAQ
VCEL
Vericel
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.